We are live on ! Find out more
TSS

Thomas Story & Son Portfolio holdings

AUM $283M
1-Year Est. Return 40%
This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+40%
3 Year Est. Return
+91.81%
5 Year Est. Return
+109.54%
10 Year Est. Return
+394.03%
AUM
$162M
AUM Growth
-$21.3M
Cap. Flow
-$26.5M
Cap. Flow %
-16.34%
Top 10 Hldgs %
45.97%
Holding
63
New
1
Increased
1
Reduced
23
Closed
7

Top Buys

Rank Stock Value
1
GNTX icon
Gentex
GNTX
+$1.55M
2
BWP
Boardwalk Pipeline Partners
BWP
+$232K

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$2.23M
2
PX
Praxair Inc
PX
+$2.08M
3
FAST icon
Fastenal
FAST
+$1.88M
4
CLR
CONTINENTAL RESOURCES INC.
CLR
+$1.83M
5
V icon
Visa
V
+$1.82M

Sector Composition

Rank Sector Weight
1 Industrials 17.78%
2 Energy 16.29%
3 Technology 12.44%
4 Healthcare 12.31%
5 Financials 11.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWP
51
DELISTED
Boardwalk Pipeline Partners
BWP
$263K 0.16%
+14,200
New +$232K
UNP icon
52
Union Pacific
UNP
$174B
$239K 0.15%
2,400
SBUX icon
53
Starbucks
SBUX
$120B
$232K 0.14%
6,000
MLKN icon
54
MillerKnoll
MLKN
$1.53B
$224K 0.14%
7,400
APH icon
55
Amphenol
APH
$198B
-128,800
Closed -$1.48M
EXPD icon
56
Expeditors International
EXPD
$22B
-22,850
Closed -$906K
FDS icon
57
Factset
FDS
$9.36B
-3,000
Closed -$323K
IDXX icon
58
Idexx Laboratories
IDXX
$44.1B
-36,700
Closed -$2.23M
CLR
59
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-29,400
Closed -$1.83M
ULTI
60
DELISTED
Ultimate Software Group Inc
ULTI
-7,700
Closed -$1.05M
AGN
61
DELISTED
Allergan Inc
AGN
-13,085
Closed -$1.62M

Similar funds

Thomas Story & Son's Q2 2014 Portfolio in Review

As of Q2 2014, Thomas Story & Son held 63 positions worth $162M, down 12% from $184M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Thomas Story & Son withdrew a net $26.5M in Q2 2014, closing 7 positions and reducing 23 holdings. Its most notable exit was Idexx Laboratories, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Energy and Technology.

Against the trend, Thomas Story & Son opened a new position in Boardwalk Pipeline Partners worth $263K.

  • Thomas Story & Son's largest Q2 2014 buy was Boardwalk Pipeline Partners: 14,200 shares worth $263K.
  • Thomas Story & Son added most to Gentex in Q2 2014, an estimated $1.55M increase.
  • Thomas Story & Son's biggest Q2 2014 reduction was Praxair Inc, cutting an estimated $2.08M.
  • Thomas Story & Son fully exited Idexx Laboratories in Q2 2014, selling an estimated $2.23M.
  • Thomas Story & Son's ten largest holdings make up 46% of its $162M portfolio in Q2 2014.
  • Thomas Story & Son opened 1 new position and closed 7 in Q2 2014.
  • Thomas Story & Son's portfolio value fell 12% quarter-over-quarter to $162M.

Based on Thomas Story & Son's 13F filing for Q2 2014, filed 1 Aug 2014.